Literature DB >> 2630443

Prognostic value of 'C' reactive protein in tuberculosis.

G Bajaj, A Rattan, P Ahmad.   

Abstract

'C' reactive protein (CRP) levels were determined in 100 cases of tuberculosis and 30 age and sex matched children. Serial estimations, one and 3 to 6 months after initiation of therapy was done in 81 and 41 of these patients, respectively. Mean initial levels of CRP in tuberculosis group was 18.52 micrograms/ml while in the control group it was 2.77 micrograms/ml (p less than 0.001). The elevated CRP levels fell significantly to 5.93 micrograms/ml after one month of treatment (p less than 0.001) and by 3 to 6 months of treatment had fallen to normal values. The fall in CRP levels correlated with clinical response. It is concluded that CRP can serve as a sensitive indicator of activity of the disease and the return to normal values of initially elevated CRP levels may indicate a good therapeutic response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2630443

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  7 in total

1.  Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

Authors:  A Jayakumar; E Vittinghoff; M R Segal; W R MacKenzie; J L Johnson; P Gitta; J Saukkonen; J Anderson; M Weiner; M Engle; C Yoon; M Kato-Maeda; P Nahid
Journal:  Tuberculosis (Edinb)       Date:  2015-05-09       Impact factor: 3.131

Review 2.  The immunology of tuberculosis: from bench to bedside.

Authors:  Keertan Dheda; Stephan K Schwander; Bingdong Zhu; Richard N van Zyl-Smit; Ying Zhang
Journal:  Respirology       Date:  2010-04       Impact factor: 6.424

3.  The Role of C-Reactive Protein as a Triage Tool for Pulmonary Tuberculosis in Children.

Authors:  Devan Jaganath; Tania F Reza; Peter Wambi; Jascent Nakafeero; Emma Kiconco; Gertrude Nanyonga; Ernest A Oumo; Moses C Nsereko; Moorine P Sekadde; Mary G Nabukenya-Mudiope; Midori Kato-Maeda; Alfred Andama; Christina Yoon; Swomitra Mohanty; Eric Wobudeya; Adithya Cattamanchi
Journal:  J Pediatric Infect Dis Soc       Date:  2022-07-21       Impact factor: 5.235

Review 4.  Assessment of treatment response in tuberculosis.

Authors:  Neesha Rockwood; Elsa du Bruyn; Thomas Morris; Robert J Wilkinson
Journal:  Expert Rev Respir Med       Date:  2016-03-31       Impact factor: 3.772

5.  Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.

Authors:  A Singanayagam; K Manalan; D W Connell; J D Chalmers; S Sridhar; A I Ritchie; A Lalvani; M Wickremasinghe; O M Kon
Journal:  Int J Tuberc Lung Dis       Date:  2016-12       Impact factor: 2.373

6.  Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.

Authors:  Catherine Riou; Blas Perez Peixoto; Lindi Roberts; Katharina Ronacher; Gerhard Walzl; Claudia Manca; Roxana Rustomjee; Thuli Mthiyane; Dorothy Fallows; Clive M Gray; Gilla Kaplan
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

7.  A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.

Authors:  Selena Ferrian; Claudia Manca; Sugnet Lubbe; Francesca Conradie; Nazir Ismail; Gilla Kaplan; Clive M Gray; Dorothy Fallows
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.